NCT04488302

Brief Summary

Objectives: Although cone-beam computed tomography (CBCT) is becoming a standard of care in implant therapy, concerns have been raised recently about its limitation in imaging peri-implant tissues due to artifacts. The aim of present study was to demonstrate the complementary role of ultrasound (US), for a comprehensive examination of peri-implant tissues in live humans. Material and Methods: Patients with \> 1 implant, a CBCT scan, an US scan, and clinical photographs taken during the open-bone surgery were included. The crestal bone thickness (CBT) and facial bone level (FBL) were measured on both modalities, and direct FBL measurements were also made on clinical images. The correlation plots were made to evaluate the measurement agreements between the 3 methods.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 7, 2020

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

July 15, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 27, 2020

Completed
Last Updated

April 13, 2026

Status Verified

July 1, 2020

Enrollment Period

7 months

First QC Date

July 15, 2020

Last Update Submit

April 7, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Crestal bone thickness

    facial bone thickness measured at 1 mm apical to bone crest

    up to 100 months after implant surgery.

Secondary Outcomes (1)

  • Facial bone height

    up to 100 months after implant surgery.

Study Arms (1)

Implant group

Patients with 1 or more implants with CBCT, ultrasound and open-bone images

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

See eligibility criteria

You may qualify if:

  • the patients had to have ≥ 1 implant with a CBCT scan, US scan, and clinical photographs taken during the surgery, e.g. a revision/explantation surgery due to peri-implantitis or a 2nd stage uncover surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

July 15, 2020

First Posted

July 27, 2020

Study Start

November 1, 2019

Primary Completion

May 30, 2020

Study Completion

July 7, 2020

Last Updated

April 13, 2026

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

No share with others

Locations